Overall rank by patents
#320
of 49,997 tracked assignees
USPTO PatentsView assignee record - 1,348 granted patents across 89 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Sanofi-aventis ranks #320 of 49,997 tracked US assignees by granted-patent volume, with 1,348 patents across 89 technology areas.
USPTO PatentsView assignee plate
Corpus R320 · Foreign Corporation #320 · 1,348 grants
GRANTS-LARGE · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Beijing Bytedance Network Technology Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
3D Systems · near
63 score
Carl Zeiss Microscopy · near
63 score
Sanofi-Aventis… · this assignee
63 score
Terumo · near
63 score
United · near
63 score
3D Lighting… · lowest
7 score
What this shows Sanofi-aventis's Innovation Score is 63.4/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Between 2020–2024, Sanofi-Aventis Deutschland GMBH received 459 grants versus 802 in 2015–2019 (-43% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2016 at 217 grants and bottomed in 2023 at 65. Lead class A61M accounts for 86% of the portfolio across 89 subclasses. Volume neighbours: Delta Faucet Company (#316) and Avago Technologies General IP (Singapore) Pte. Ltd. (#324).
From 2019–2021 to 2022–2024, Sanofi-Aventis Deutschland GMBH moved from 401 to 225 grants (0.56x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,543. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Delta Faucet Company
1,351 patents
Acer Incorporated
1,350 patents
ExxonMobil Chemical Patents Inc.
1,350 patents
Beijing Bytedance Network Technology Co., Ltd.
1,348 patents
Sanofi-Aventis Deutschland GMBH
1,348 patents
Harman International Industries, Incorporated
1,341 patents
Kubota Corporation
1,340 patents
Cook Medical Technologies LLC
1,327 patents
Avago Technologies General IP (Singapore) Pte. Ltd.
1,321 patents
What this shows Sanofi-Aventis holds 1,348 patents at rank #320, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #320 in granted patent volume.
Other assignees with the most granted patents in Sanofi-Aventis's primary technology class.
Two PlainPatent-derived peer sets for Sanofi-Aventis, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (63 here).
Nearest assignees by average claims per patent (16.3 here).
Sanofi-aventis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
63 Top 2% higher than 98% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 121 | 9.0% |
| 2016 | 217 | 16.1% |
| 2017 | 184 | 13.6% |
| 2018 | 113 | 8.4% |
| 2019 | 167 | 12.4% |
| 2020 | 126 | 9.3% |
| 2021 | 108 | 8.0% |
| 2022 | 94 | 7.0% |
| 2023 | 65 | 4.8% |
| 2024 | 66 | 4.9% |
| 2025partial year | 87 | 6.5% |
Top 15 of 89 technology areas
Overall rank by patents
#320
of 49,997 tracked assignees
63.4 out of 100
What to do with this data
Sanofi-Aventis Deutschland GMBH's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.